SMAD4 and malignant colon neoplasm: Thus, Smad4-deficient colon cancer cells not only evade TGFβ-induced growth inhibition through Smad4 deletion but also actively respond to TGFβ-induced tumor progression at least through ID1 stabilization, thus reflecting their high malignancy.